Diabetic nephropathy: What does the future hold?

The consensus management of diabetic nephropathy (DN) in 2015 involves good control of glycaemia, dyslipidaemia and blood pressure (BP). Blockade of the renin–angiotensin–aldosterone system using angiotensin-converting enzyme inhibitors, angiotensin-2 receptor blockers or mineralocorticoid inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Montero, R. M., Covic, A., Gnudi, L., Goldsmith, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2015
Materias:
Nephrology - Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705119/
https://www.ncbi.nlm.nih.gov/pubmed/26438328
http://dx.doi.org/10.1007/s11255-015-1121-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705119/
https://www.ncbi.nlm.nih.gov/pubmed/26438328
http://dx.doi.org/10.1007/s11255-015-1121-y

Ejemplares similares